Amendment AGREEMENTAmendment Agreement • August 14th, 2024 • TNF Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledAugust 14th, 2024 Company IndustryThis Amendment Agreement (this “Agreement”), dated as of August 8, 2024, is by and between TNF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).